Which are the demographic and clinical characteristics of patients who respond to subcutaneous esketamine?

Abstract

Get full access to this article

View all access options for this article.

References

American Psychiatric Association (1994) Diagnostical and Statistical Manual of Mental Disorders (DSM-IV), 4th edn. Washington, D.C.: American Psychiatric Association.

American Psychiatric Association (2013) Diagnostical and Statistical Manual of Mental Disorders (DSM-5), 5th edn. Arlington, VA: American Psychiatric Association.

Fekadu

Wooderson

Markopoulou

, et al. (2009) The Maudsley Staging Method for treatment-resistant depression: Prediction of longer-term outcome and persistence of symptoms. J Clin Psychiatry 70: 952–957.

Lucchese

Sarin

Magalhães

EJM

, et al. (2021) Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity. J Psychopharmacol 35: 142–149.